Somatropin promising in HIV-associated lipodystrophy

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1311, 2001-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiretrovirals: HIV-associated lipodystrophy: 3 case reports

Reactions Weekly, Vol. 1, Iss. 1335, 2011-01 ,pp. : 8-9

Adis International

Access to resources Recommend Favorite

Tesamorelin: A Review of its Use in the Management of HIV-Associated Lipodystrophy

By Dhillon Sohita

Drugs, Vol. 71, Iss. 8, 2011-05 ,pp. : 1071-1091

Adis International

Access to resources Recommend Favorite

Mammalian cell-derived somatropin increases bodyweight and lean body mass in patients with HIV-associated wasting

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 22, Iss. 10, 2006-10 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Mammalian Cell-Derived Somatropin: A Review of its Use in the Management of HIV-Associated Wasting

By Goldsmith David R. Wagstaff Antona J.

Drugs, Vol. 66, Iss. 3, 2006-01 ,pp. : 387-401

Adis International

Access to resources Recommend Favorite

Metreleptin promising in lipodystrophy

Inpharma, Vol. 1, Iss. 1327, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite